Intravenous methylprednisolone in minimal change nephrotic syndrome

C. Ponticelli, E. Imbasciati, N. Case, P. Zucchelli, L. Cagnoli, S. Pasquali

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Prednisone by mouth in large doses usually reverses minimal change nephrotic syndrome but there may be severe side effects, particularly in patients with frequent relapses. We therefore tried a new regiment beginning with three consecutive pulses of intravenous methylprednisolone and following these with prednisone by mouth in low doses (15-20 mg/kg). The urine became protein free in all our patients and a remission was reached even in frequent relapsers. Three patients with heavy proteinuria in relapse rapidly responded to further treatment with intravenous methylprednisolone. None of our patients suffered from hypercorticism or other side effects. These preliminary results seem to indicate that our regimen might be effective and well tolerated in most patients with lipoid nephrosis.

Original languageEnglish
Pages (from-to)685
Number of pages1
JournalBritish Medical Journal
Volume280
Issue number6215
Publication statusPublished - 1980

Fingerprint

Lipoid Nephrosis
Methylprednisolone
Prednisone
Mouth
Adrenocortical Hyperfunction
Recurrence
Proteinuria
Urine
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ponticelli, C., Imbasciati, E., Case, N., Zucchelli, P., Cagnoli, L., & Pasquali, S. (1980). Intravenous methylprednisolone in minimal change nephrotic syndrome. British Medical Journal, 280(6215), 685.

Intravenous methylprednisolone in minimal change nephrotic syndrome. / Ponticelli, C.; Imbasciati, E.; Case, N.; Zucchelli, P.; Cagnoli, L.; Pasquali, S.

In: British Medical Journal, Vol. 280, No. 6215, 1980, p. 685.

Research output: Contribution to journalArticle

Ponticelli, C, Imbasciati, E, Case, N, Zucchelli, P, Cagnoli, L & Pasquali, S 1980, 'Intravenous methylprednisolone in minimal change nephrotic syndrome', British Medical Journal, vol. 280, no. 6215, pp. 685.
Ponticelli C, Imbasciati E, Case N, Zucchelli P, Cagnoli L, Pasquali S. Intravenous methylprednisolone in minimal change nephrotic syndrome. British Medical Journal. 1980;280(6215):685.
Ponticelli, C. ; Imbasciati, E. ; Case, N. ; Zucchelli, P. ; Cagnoli, L. ; Pasquali, S. / Intravenous methylprednisolone in minimal change nephrotic syndrome. In: British Medical Journal. 1980 ; Vol. 280, No. 6215. pp. 685.
@article{8f6fd7e41a324d918dc24d7d90da376d,
title = "Intravenous methylprednisolone in minimal change nephrotic syndrome",
abstract = "Prednisone by mouth in large doses usually reverses minimal change nephrotic syndrome but there may be severe side effects, particularly in patients with frequent relapses. We therefore tried a new regiment beginning with three consecutive pulses of intravenous methylprednisolone and following these with prednisone by mouth in low doses (15-20 mg/kg). The urine became protein free in all our patients and a remission was reached even in frequent relapsers. Three patients with heavy proteinuria in relapse rapidly responded to further treatment with intravenous methylprednisolone. None of our patients suffered from hypercorticism or other side effects. These preliminary results seem to indicate that our regimen might be effective and well tolerated in most patients with lipoid nephrosis.",
author = "C. Ponticelli and E. Imbasciati and N. Case and P. Zucchelli and L. Cagnoli and S. Pasquali",
year = "1980",
language = "English",
volume = "280",
pages = "685",
journal = "British Medical Journal",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "6215",

}

TY - JOUR

T1 - Intravenous methylprednisolone in minimal change nephrotic syndrome

AU - Ponticelli, C.

AU - Imbasciati, E.

AU - Case, N.

AU - Zucchelli, P.

AU - Cagnoli, L.

AU - Pasquali, S.

PY - 1980

Y1 - 1980

N2 - Prednisone by mouth in large doses usually reverses minimal change nephrotic syndrome but there may be severe side effects, particularly in patients with frequent relapses. We therefore tried a new regiment beginning with three consecutive pulses of intravenous methylprednisolone and following these with prednisone by mouth in low doses (15-20 mg/kg). The urine became protein free in all our patients and a remission was reached even in frequent relapsers. Three patients with heavy proteinuria in relapse rapidly responded to further treatment with intravenous methylprednisolone. None of our patients suffered from hypercorticism or other side effects. These preliminary results seem to indicate that our regimen might be effective and well tolerated in most patients with lipoid nephrosis.

AB - Prednisone by mouth in large doses usually reverses minimal change nephrotic syndrome but there may be severe side effects, particularly in patients with frequent relapses. We therefore tried a new regiment beginning with three consecutive pulses of intravenous methylprednisolone and following these with prednisone by mouth in low doses (15-20 mg/kg). The urine became protein free in all our patients and a remission was reached even in frequent relapsers. Three patients with heavy proteinuria in relapse rapidly responded to further treatment with intravenous methylprednisolone. None of our patients suffered from hypercorticism or other side effects. These preliminary results seem to indicate that our regimen might be effective and well tolerated in most patients with lipoid nephrosis.

UR - http://www.scopus.com/inward/record.url?scp=0018841212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018841212&partnerID=8YFLogxK

M3 - Article

C2 - 7363021

AN - SCOPUS:0018841212

VL - 280

SP - 685

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8146

IS - 6215

ER -